8-KItem 2.03 · Financial ObligationItem 8.01 · Other EventsItem 9.01 · Financial Statements
METLIFE INC (MET)

MetLife ($MET) on Feb 24, 2026 entered underwriting and pricing agreements for sale of debentures with…

Filed with the SEC on · Summarized by InvestorsBot

MetLife ($MET) on Feb 24, 2026 entered underwriting and pricing agreements for sale of debentures with lead underwriters Barclays, BofA Securities, Citi, Goldman Sachs, Morgan Stanley and Wells Fargo. 🏦📄 #Debentures #Bonds #MetLife

Willkie Farr & Gallagher provided opinion letters attached as Exhibits 5.1 (validity) and 8.1 (certain U.S. federal income tax matters) relating to the debentures. See the 8‑K for full docs and pricing/amount details. $MET 🧾⚖️ #SECfiling #Tax

Read the original filing on SEC EDGAR

Get summaries like this in your inbox every morning

Pick up to 20 companies — we read their SEC filings overnight and send you the plain-English version. Free.

Subscribe free

More from METLIFE INC

MetLife ($MET) confirmed declaration of a Q1 2026 dividend on its floating-rate, non‑cumulative preferred…

8-K · March 5, 2026

MetLife (Mar 5, 2026) confirms first quarter 2026 dividend of $0.31501229 per share on its floating-rate,…

8-K · March 5, 2026

METLIFE filed Underwriting & Pricing Agreements dated Feb 24, 2026 with lead bookrunners Barclays, BofA,…

8-K · February 26, 2026

MetLife issued $1,000,000,000 of 5.850% Fixed‑to‑Fixed Reset Rate Subordinated Debentures due 2056 on Feb…

8-K · February 26, 2026

MetLife ($MET) Board increased directors from 11 to 13 and on Feb 24, 2026 elected Daniel S.

8-K · February 24, 2026

MetLife ($MET) declared dividends in a news release dated Feb 17, 2026: semi-annual on 5.875%…

8-K · February 17, 2026